Equitec Specialists’s Idexx Laboratories IDXX Stock Holding History

Equitec Specialists’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-102	Closed	-$27K	–	138
2019 Q4	$27K	Buy	+102	New	+$26.9K	0.01%	118

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Equitec Specialists's IDXX Position: Q1 2020 in Review

Equitec Specialists sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 102 shares — an estimated $27K sold.

Equitec Specialists first reported a position in IDXX in Q4 2019 and held it in 1 quarter. The position peaked at $27K in Q4 2019. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

Equitec Specialists reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
Equitec Specialists sold 102 Idexx Laboratories shares in Q1 2020, an estimated $27K.
Equitec Specialists first reported a position in Idexx Laboratories in Q4 2019 and held it in 1 quarter.
Equitec Specialists's Idexx Laboratories position peaked at $27K in Q4 2019.
748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Equitec Specialists's 13F filing for Q1 2020, filed 23 Apr 2020.